JOURNAL OF GLAUCOMA, vol.24, no.1, pp.1-8, 2015 (SCI-Expanded)
Purpose: To compare the safety and efficacy of primary trabeculectomy with adjunctive subconjunctival bevacizumab with that of primary trabeculectomy with mitomycin C (MMC).